MGAM
LLY icon

McGowan Group Asset Management’s Eli Lilly LLY Stock Holding History

McGowan Group Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.5M Sell
21,250
-208
-1% -$211K 2.49% 13
2025
Q4 		$23.1M Sell
21,458
-116
-0.5% -$111K 2.86% 11
2025
Q3 		$16.5M Sell
21,574
-33
-0.2% -$24.6K 2.04% 16
2025
Q2 		$16.8M Sell
21,607
-201
-0.9% -$156K 2.12% 15
2025
Q1 		$18M Buy
21,808
+30
+0.1% +$25K 2.38% 13
2024
Q4 		$16.8M Sell
21,778
-24
-0.1% -$19.9K 2.25% 11
2024
Q3 		$19.3M Sell
21,802
-126
-0.6% -$113K 2.54% 11
2024
Q2 		$19.9M Sell
21,928
-279
-1% -$223K 2.76% 13
2024
Q1 		$17.3M Sell
22,207
-33
-0.1% -$23.5K 2.49% 17
2023
Q4 		$13M Sell
22,240
-63
-0.3% -$36.8K 2.08% 17
2023
Q3 		$12M Sell
22,303
-109
-0.5% -$56.2K 1.89% 18
2023
Q2 		$10.5M Buy
22,412
+104
+0.5% +$43.6K 1.64% 18
2023
Q1 		$7.66M Buy
22,308
+72
+0.3% +$24.3K 1.22% 21
2022
Q4 		$8.13M Buy
22,236
+3
+0% +$1.06K 1.3% 21
2022
Q3 		$7.19M Sell
22,233
-596
-3% -$189K 1.25% 22
2022
Q2 		$7.4M Buy
22,829
+28
+0.1% +$8.4K 1.24% 22
2022
Q1 		$6.53M Sell
22,801
-30
-0.1% -$7.72K 1% 23
2021
Q4 		$6.31M Buy
22,831
+21
+0.1% +$5.32K 1.11% 23
2021
Q3 		$5.27M Buy
22,810
+29
+0.1% +$7.16K 0.9% 25
2021
Q2 		$5.23M Sell
22,781
-295
-1% -$59.3K 0.82% 25
2021
Q1 		$4.31M Buy
23,076
+9
+0% +$1.76K 0.7% 29
2020
Q4 		$3.9M Sell
23,067
-225
-1% -$33.6K 0.67% 31
2020
Q3 		$3.45M Buy
23,292
+951
+4% +$147K 0.65% 32
2020
Q2 		$3.67M Buy
22,341
+146
+0.7% +$22.4K 0.68% 32
2020
Q1 		$3.08M Buy
22,195
+1,384
+7% +$190K 0.67% 29
2019
Q4 		$2.73M Sell
20,811
-90
-0.4% -$10.4K 0.47% 30
2019
Q3 		$2.34M Buy
20,901
+1
+0% +$111 0.38% 32
2019
Q2 		$2.32M Sell
20,900
-30
-0.1% -$3.53K 0.36% 38
2019
Q1 		$2.72M Hold
20,930
– – 0.43% 38
2018
Q4 		$2.42M Sell
20,930
-419
-2% -$46.8K 0.44% 38
2018
Q3 		$2.29M Hold
21,349
– – 0.38% 37
2018
Q2 		$1.82M Hold
21,349
– – 0.31% 37
2018
Q1 		$1.65M Hold
21,349
– – 0.28% 41
2017
Q4 		$1.8M Hold
21,349
– – 0.29% 37
2017
Q3 		$1.83M Hold
21,349
– – 0.36% 32
2017
Q2 		$1.76M Buy
21,349
+1
+0% +$82 0.36% 34
2017
Q1 		$1.8M Hold
21,348
– – 0.36% 32
2016
Q4 		$1.57M Hold
21,348
– – 0.33% 36
2016
Q3 		$1.71M Hold
21,348
– – 0.33% 45
2016
Q2 		$1.68M Sell
21,348
-144
-0.7% -$10.8K 0.3% 55
2016
Q1 		$1.55M Hold
21,492
– – 0.3% 58
2015
Q4 		$1.81M Sell
21,492
-3,650
-15% -$303K 0.36% 57
2015
Q3 		$2.1M Sell
25,142
-110
-0.4% -$9.29K 0.42% 50
2015
Q2 		$2.11M Hold
25,252
– – 0.43% 45
2015
Q1 		$1.83M Hold
25,252
– – 0.37% 42
2014
Q4 		$1.74M Buy
+25,252
New +$1.7M 0.35% 57

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

McGowan Group Asset Management's LLY Position: Q1 2026 in Review

McGowan Group Asset Management reduced its Eli Lilly (LLY) stake by 0.97% in Q1 2026, selling an estimated $211K and leaving 21,250 shares worth $19.5M. The position accounts for 2.49% of the portfolio, ranked #13.

McGowan Group Asset Management first reported a position in LLY in Q4 2014 and has held it in 46 quarters since. The position peaked at $23.1M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • McGowan Group Asset Management held 21,250 shares of Eli Lilly worth $19.5M as of Q1 2026.
  • McGowan Group Asset Management sold 208 Eli Lilly shares in Q1 2026, an estimated $211K.
  • Eli Lilly made up 2.49% of McGowan Group Asset Management's portfolio in Q1 2026, its #13 holding.
  • McGowan Group Asset Management first reported a position in Eli Lilly in Q4 2014 and has held it in 46 quarters since.
  • McGowan Group Asset Management's Eli Lilly position peaked at $23.1M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on McGowan Group Asset Management's 13F filing for Q1 2026, filed 11 May 2026.